TITLE

Crocin or Paracetamol

AUTHOR(S)
CHATTERJEE, CHIRANTAN; KENSUKE KUBO; PINGALI, VISWANATH
PUB. DATE
October 2013
SOURCE
Economic & Political Weekly;10/12/2013, Vol. 48 Issue 41, p20
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
As the Indian government contemplates enacting generic name-based prescriptions, it is important to understand the pros and cons of such regulation. This article points out various advantages associated with such changes in doctor behaviour, while pointing out potential issues with it. It argues that while the prices of older drugs might come down because of the new regulation, other issues pertaining to quality might arise.
ACCESSION #
101530937

 

Related Articles

  • Israel introduces generic drugs scheme. Siegel-Itzkovich, Judy // BMJ: British Medical Journal (International Edition);09/04/99, Vol. 319 Issue 7210, p592 

    Reports on the implementation of a generic drug scheme in Israel. Anticipated benefit of the scheme; Position of pharmaceutical companies on the issue; Implications of the rules on pharmaceutical imports.

  • Economía de los medicamentos genéricos en América Latina. Tobar, Federico // Revista Panamericana de Salud Publica;Feb2010, Vol. 27 Issue 2, p59 

    In terms of economics, implementing generic drug policy is nothing other than consolidating (or even, creating) drug markets that set competitive prices, the result of which favors public access to essential drugs. This article approaches the topic of generic drugs from the economic perspective...

  • Canadian Pharmacies Facing Steep Reimbursement Cuts.  // Chain Drug Review;8/30/2010, Vol. 32 Issue 14, p46 

    The article reports on the changes in the reimbursement plans for the pharmaceutical industry in Canada. It highlights the new regulations imposed in Ontario which include prohibition of professional allowances by generic drug manufacturers, establishment of ceilings on the price of generic...

  • Plans for nurses to supply morphine.  // Pulse;3/29/2007, Vol. 67 Issue 12, p3 

    The article reports on the government's proposal on expansion of non-medical prescribing which permits all nurses and pharmaceuticals to supply and distribute morphine as treatment drug. According to the report that only 12 controlled drugs are allowed to prescribe by the nurses. Its main...

  • European Union criticised for restricting access of developing countries to cheap generic drugs. Watson, Rory // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;10/24/2009, Vol. 339 Issue 7727, p937 

    The article deals with criticisms contained in a report published by Oxfam and Health Action International Europe on October 20, 2000 on the European Union's double standards on cheap generic drugs. The European Union is accused of exerting efforts to reduce the price of generic drugs in the...

  • Coutu Braces for Change.  // Chain Drug Review;8/30/2010, Vol. 32 Issue 14, p94 

    The article reports on the reaction of Jean Coutu Group (PJC) USA Inc. to adjustments made by the Quebec government to generic drug prices. It is said that Jean Coutu Group (PJC) USA Inc. is less pessimistic about the regulatory changes than its competitors and expects another adjustment in the...

  • Quality achievement does not cost more.  // GP: General Practitioner;8/4/2006, p4 

    The article reports on a study which has revealed that high achievement on quality indicators does not lead to spiraling prescribing costs. The researchers collected data related to the top seven life-saving prescribing interventions in general practice in 2003 from 71 practices in Norfolk and...

  • Tips for Managing Your Prescription Drug Costs. Duritz, Nicole // Jackson Advocate;7/4/2013, Vol. 75 Issue 39, p7B 

    The article outlines some tips on how to manage the costs of prescription drugs by considering generic drugs, ordering drug comparison guides and getting health coverage.

  • Coalition seeks quicker approval of generic Rxs.  // Drug Topics;8/7/95, Vol. 139 Issue 15, p24 

    Reports on the efforts by a coalition of consumer and industry groups to persuade the US Congress to overturn a decision by the US Food and Drug Administration. Postponement of anticipated generic competition for drugs such as Zantac and Capoten; Lobbying efforts by Gray Panthers, the National...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics